Christine Zedelmayer

Christine is the Chief Operating Officer at Equillium. Prior to Equillium, she was Principal Consultant at Centerra Consulting, a project management and investor relations consulting firm focused on life sciences based in Southern California. While at Centerra, Christine led strategic business development projects for her clients and served as head of investor relations for a variety of medical device companies. Prior to Centerra, Christine held a variety of roles during her 10-year tenure at Amylin Pharmaceuticals, including Senior Director of Alliance Management, where she led the global collaboration with Eli Lilly and as Executive Director of Investor Relations. Before joining Amylin, Christine also held various leadership positions within project management at Amgen, Ligand Pharmaceuticals and Hybritech.

Christine received her Bachelor of Science in Electrical Engineering at San Diego State University and a Master of Business Administration with Finance emphasis at California Lutheran University. She is also a certified Project Management Professional (PMI-PMP, license #1602309).